A Retrospective Cohort Study Comparing Persistence Between Rimegepant and Oral Triptans for the Acute Treatment of Migraine in the United States (P10-12.008)
To compare 12-month medication persistence between patients receiving rimegepant and oral triptans as needed for the acute treatment of migraine in the US.
Authors
- Joanna Atkinson (ORCID: https://orcid.org/0000-0003-4592-1682)
- Motomori O. Lewis (ORCID: https://orcid.org/0000-0001-5533-0830)
- Carl Henriksen (ORCID: https://orcid.org/0000-0003-1599-4696)
- Lucy Abraham (ORCID: https://orcid.org/0000-0003-1648-8621)
- Michelle Ho (ORCID: https://orcid.org/0009-0009-5412-5929)
- Aaron Jenkins (ORCID: https://orcid.org/0000-0001-9785-9388)
- Feng Dai (ORCID: https://orcid.org/0000-0002-9963-6863)
Institutions
- Pfizer (United States) (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000208546
- Primary Topic
- Migraine and Headache Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00